Somatostatinoma

Somatostatinoma is a rare type of tumor that develops in the pancreas or the digestive tract. It affects the body's ability to regulate important hormones because it produces too much somatostatin, a hormone that normally controls the release of other hormones. This excess can lead to problems like diabetes, gallstones, and digestive issues such as diarrhea and weight loss. The tumor involves the endocrine system, which is responsible for hormone production and regulation. Because it disrupts hormone balance, it can cause a variety of symptoms that affect metabolism and digestion. Early detection is important to manage the effects on health.

Somatostatinoma is a rare neuroendocrine tumor arising primarily from the delta cells of the pancreas or the duodenum. It is characterized by the excessive secretion of somatostatin, a hormone that inhibits the release of several other hormones including insulin, glucagon, and gastrin. This hormonal imbalance leads to a clinical syndrome marked by diabetes mellitus, cholelithiasis (gallstones), steatorrhea, and weight loss. The tumor is often malignant and may present with nonspecific symptoms or as part of a pancreatic neuroendocrine tumor spectrum. Diagnosis is significant due to the tumor’s potential for local invasion and metastasis. The pathophysiology involves inhibition of endocrine and exocrine pancreatic functions, contributing to the characteristic clinical features.